Telo Therapeutics

About:

Telo Therapeutics is a novel precision medicine approach to reverse cancer cell immortality.

Website: http://telotherapeutics.com

Top Investors: Mission BioCapital, Viva BioInnovator

Description:

Telo Therapeutics operates a biotechnology company intended to develop medicine to reverse cancer cell immortality. The company's medicine specializes in inhibiting cancer cell immortality by undergoing the immortalization process, leaving healthy cells intact, enabling patients to get cured of diseases such as cancer.

Total Funding Amount:

$4.71M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)telotherapeutics.com

Founders:

Joseph Costello, Rob Bell

Number of Employees:

1-10

Last Funding Date:

2021-06-22

IPO Status:

Private

Industries: